The FDA Has Recently Required Drug Companies to Provide Warnings

The FDA has recently required drug companies to provide warnings on the labels of all antidepressants because of evidence that these drugs may induce

A) suicidal ideation or behaviors in a small proportion of depressed patients at the beginning of their treatment
B) parkinsonian-like symptoms in elderly patients
C) hypertensive crises when combined with certain foods or other drugs
D) convulsions in certain patients